Supplementary Fig. 1A from LILRB3 Supports Immunosuppressive Activity of Myeloid Cells and Tumor Development

Ryan Huang,Xiaoye Liu,Jaehyup Kim,Hui Deng,Mi Deng,Xun Gui,Heyu Chen,Guojin Wu,Wei Xiong,Jingjing Xie,Cheryl Lewis,Jade Homsi,Xing Yang,Chengcheng Zhang,Yubo He,Qi Lou,Caroline Smith,Samuel John,Ningyan Zhang,Zhiqiang An,Cheng

DOI: https://doi.org/10.1158/2326-6066.25338410

2024-01-01

Abstract:Supplementary Fig. 1A with figure legend

What problem does this paper attempt to address?

Supplementary Figures S1-S8 from <i>a. Muciniphila</i> Suppresses Colorectal Tumorigenesis by Inducing TLR2/NLRP3-Mediated M1-Like TAMs

Lina Fan,Chaochao Xu,Qiwei Ge,Yifeng Lin,Jun Yu,Qi Yue,Bin Ye,Qingwu Lian,Wei Zhuo,Jianmin Si,Shujie Chen,Liangjing Wang

DOI: https://doi.org/10.1158/2326-6066.22543939.v1

2023-01-01

Abstract:Supplementary Figures and Legends
Supplemetal Data from Genetic Ablation of Rbm38 Promotes Lymphomagenesis in the Context of Mutant P53 by Downregulating PTEN

Jin Zhang,Enshun Xu,Cong Ren,Hee Jung Yang,Yanhong Zhang,Wenqiang Sun,Xiangmudong Kong,Weici Zhang,Mingyi Chen,Eric Huang,Xinbin Chen

DOI: https://doi.org/10.1158/0008-5472.22417952

2023-01-01

Abstract:Supplemental Fig. S1 represents analysis of TLBL. Supplemental Fig. S2 contains representative images of H.E.-stained tumors. Supplemental Fig. S3 contains RT-PCR analysis of various genes (Tbet, NFAT1,NFAT2, IFNG, IL6) in thymus and TLBLs. Supplemental table S1-4 contains gender, survival, and tumor information of the mice.
Supplementary Figure from HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis

Jiahui Mou,Meijun Huang,Feifei Wang,Xiaoding Xu,Hanqi Xie,Henglei Lu,Mingyang Li,Yu Li,Weiwen Kong,Jing Chen,Ying Xiao,Yiding Chen,Chaochen Wang,Jin Ren

DOI: https://doi.org/10.1158/1541-7786.22527890

2023-01-01

Abstract:Supplementary Figure from HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis
Supplementary Figure S3 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC

Sonia A. Patel,Monique B. Nilsson,Yan Yang,Xiuning Le,Hai T. Tran,Yasir Y. Elamin,Xiaoxing Yu,Fahao Zhang,Alissa Poteete,Xiaoyang Ren,Li Shen,Jing Wang,Seyed Javad Moghaddam,Tina Cascone,Michael Curran,Don L. Gibbons,John V. Heymach

DOI: https://doi.org/10.1158/1078-0432.22494757.v1

2023-01-01

Abstract:EGFR-mutant NSCLC EGFR-independent tumor model is refractory to EGFR-TKI treatment.
LILRB3 supports acute myeloid leukemia development and regulates T-cell antitumor immune responses through the TRAF2–cFLIP–NF-κB signaling axis

Guojin Wu,Yixiang Xu,Robbie D. Schultz,Heyu Chen,Jingjing Xie,Mi Deng,Xiaoye Liu,Xun Gui,Samuel John,Zhigang Lu,Hisashi Arase,Ningyan Zhang,Zhiqiang An,Cheng Cheng Zhang

DOI: https://doi.org/10.1038/s43018-021-00262-0

IF: 22.7

2021-01-01

Nature Cancer

Abstract:Leukocyte immunoglobulin-like receptor B (LILRB), a family of immune checkpoint receptors, contributes to acute myeloid leukemia (AML) development, but the specific mechanisms triggered by activation or inhibition of these immune checkpoints in cancer is largely unknown. Here we demonstrate that the intracellular domain of LILRB3 is constitutively associated with the adaptor protein TRAF2. Activated LILRB3 in AML cells leads to recruitment of cFLIP and subsequent NF-κB upregulation, resulting in enhanced leukemic cell survival and inhibition of T-cell-mediated anti-tumor activity. Hyperactivation of NF-κB induces a negative regulatory feedback loop mediated by A20, which disrupts the interaction of LILRB3 and TRAF2; consequently the SHP-1/2-mediated inhibitory activity of LILRB3 becomes dominant. Finally, we show that blockade of LILRB3 signaling with antagonizing antibodies hampers AML progression. LILRB3 thus exerts context-dependent activating and inhibitory functions, and targeting LILRB3 may become a potential therapeutic strategy for AML treatment.
Supplementary Figure S6 from CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ

Hangyi H. Yan,Jiang Jian,Yanli Pang,B.R. Achyut,Michael M. Lizardo,Xinhua Liu,Kent W. Hunter,Chand Khanna,Christine M. Hollander,Li Yang

DOI: https://doi.org/10.1158/0008-5472.22407845

2023-01-01

Abstract:Fold increase in myeloid cell subsets in the lungs.
Supplementary Figure Legend from CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ

Hangyi H. Yan,Jiang Jian,Yanli Pang,B.R. Achyut,Michael M. Lizardo,Xinhua Liu,Kent W. Hunter,Chand Khanna,Christine M. Hollander,Li Yang

DOI: https://doi.org/10.1158/0008-5472.22407863

2023-01-01

Abstract:Legend for Supplementary Figures S1-S6.
Supplementary Figure S5 from AMBRA1 Promotes TGFβ Signaling Via Nonproteolytic Polyubiquitylation of Smad4

Jinquan Liu,Bo Yuan,Jin Cao,Hongjie Luo,Shuchen Gu,Mengdi Zhang,Ran Ding,Long Zhang,Fangfang Zhou,Mien-Chie Hung,Pinglong Xu,Xia Lin,Jianping Jin,Xin-Hua Feng

DOI: https://doi.org/10.1158/0008-5472.22429066

2023-01-01

Abstract:AMBRA1 is critical for TGF-β-induced EMT, migration, and invasion.
Supplementary Figure S1 from CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ

Hangyi H. Yan,Jiang Jian,Yanli Pang,B.R. Achyut,Michael M. Lizardo,Xinhua Liu,Kent W. Hunter,Chand Khanna,Christine M. Hollander,Li Yang

DOI: https://doi.org/10.1158/0008-5472.22407860

2023-01-01

Abstract:Myeloid cells, CCL9 and its effect on tumor phenotype.
Supplementary Figure 3 from TGF-β Signaling in Myeloid Cells is Required for Tumor Metastasis

Yanli Pang,Sudheer Kumar Gara,Bhagelu R. Achyut,Zhaoyang Li,Hannah H. Yan,Chi‐Ping Day,Jonathan M. Weiss,Giorgio Trinchieri,John C. Morris,Li Yang

DOI: https://doi.org/10.1158/2159-8290.22530060.v1

2023-01-01

Abstract:Supplementary Figure 3 - PDF file 76K, IFN-gamma production by T cells and its effect on tumor growth in Tgfbr2MyeKOand Tgfbr2flox/flox control mice
Supplementary Figure 7 from TGF-β Signaling in Myeloid Cells is Required for Tumor Metastasis

Yanli Pang,Sudheer Kumar Gara,Bhagelu R. Achyut,Zhaoyang Li,Hannah H. Yan,Chi‐Ping Day,Jonathan M. Weiss,Giorgio Trinchieri,John C. Morris,Li Yang

DOI: https://doi.org/10.1158/2159-8290.22530048.v1

2023-01-01

Abstract:Supplementary Figure 7 - PDF file 111K, Characterization of myeloid cells in lung, tumor, spleen, and lymph nodes
Figure S4 from Disrupting LILRB4/APOE Interaction by an Efficacious Humanized Antibody Reverses T-cell Suppression and Blocks AML Development

Xun Gui,Mi Deng,Hao Song,Yuanzhi Chen,Jingjing Xie,Zunling Li,Licai He,Fangfang Huang,Yixiang Xu,Yasuaki Anami,Hai Yu,Chenyi Yu,Leike Li,Zihao Yuan,Xiaoying Xu,Qihui Wang,Yan Chai,Tao Huang,Yi Shi,Kyoji Tsuchikama,X. Charlene Liao,Ningshao Xia,George F. Gao,Ningyan Zhang,Cheng,Zhiqiang An

DOI: https://doi.org/10.1158/2326-6066.22543509

2023-01-01

Abstract:Phylogenetic analysis of D1 amino acid sequences of leukocyte immunoglobulin like receptors (LILRs).
Supplementary Figure 8 from TGF-β Signaling in Myeloid Cells is Required for Tumor Metastasis

Yanli Pang,Sudheer Kumar Gara,Bhagelu R. Achyut,Zhaoyang Li,Hannah H. Yan,Chi‐Ping Day,Jonathan M. Weiss,Giorgio Trinchieri,John C. Morris,Li Yang

DOI: https://doi.org/10.1158/2159-8290.22530045.v1

2023-01-01

Abstract:Supplementary Figure 8 - PDF file 84K, Immune cell profiling and IFN-gamma production in CD8 T cells in tumor tissues between Tgfbr2flox/flox and Tgfbr2MyeKO mice bearing 4T1 tumors
Supplementary Figure S4 from CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ

Hangyi H. Yan,Jiang Jian,Yanli Pang,B.R. Achyut,Michael M. Lizardo,Xinhua Liu,Kent W. Hunter,Chand Khanna,Christine M. Hollander,Li Yang

DOI: https://doi.org/10.1158/0008-5472.22407851

2023-01-01

Abstract:CCL9 promotes tumor cell survival and colonization.
Supplemental Figures S1-S11 from PBX3 and MEIS1 Cooperate in Hematopoietic Cells to Drive Acute Myeloid Leukemias Characterized by a Core Transcriptome of the MLL-Rearranged Disease

Zejuan Li,Ping Chen,Rui Su,Chao Hu,Yuanyuan Li,Abdel G. Elkahloun,Zhixiang Zuo,Sandeep Gurbuxani,Stephen Arnovitz,Hengyou Weng,Yungui Wang,Shenglai Li,Hao Huang,Mary Beth Neilly,Gang Greg Wang,Xi Jiang,Paul P. Liu,Jie Jin,Jianjun Chen

DOI: https://doi.org/10.1158/0008-5472.22408341.v1

2023-01-01

Abstract:Flow cytometry analysis of leukemic bone marrow cells from recipient mice of primary BM transplantation (S1); Comparison of leukemic latency between secondary BMT recipient mice transplanted with primary leukemic BM cells from two donor mice of each group (S2); Gene Set Enrichment Analysis of genes differentially expressed between different groups of samples (S3); Gene Set Enrichment Analysis of gene sets that are significantly differentially enriched between Group 2 samples and the PBX3+MEIS1 samples (S4); Analysis of genes significantly differentially expressed between three hierarchical clustering groups (S5); Heatmap of expression profiles of the 211 genes that are expressed at a significantly lower level in Group 3 than in both Groups 1 and 2 (S6); Heatmap of expression profiles of the 279 genes that are expressed at a significantly higher level in Group 2 than in both Groups 1 and 3 (S7); Heatmap of expression profiles of the 85 genes that are expressed at a significantly lower level in Group 2 than in both Groups 1 and 3 (S8); Heatmap of expression profiles of a set of 166 genes that are expressed at a significantly higher level in Group 1 than in both Groups 2 and 3, and are also associated with cell death/apoptosis and hematopoietic cell differentiation pathways according to DAVID analysis (S9); Heatmap of expression profiles of representative gene sets that are expressed at a significantly lower level in Group 3 samples than in both Groups 1 and 2 samples (S10); The effect of forced expression of HOXA9 on the expression of endogenous Hoxa genes in PBX3+MEIS1 AML cells (S11).
Supplementary Figures 1-7 from Gr-1+CD11b+ Myeloid Cells Tip the Balance of Immune Protection to Tumor Promotion in the Premetastatic Lung

Hannah H. Yan,Michael Pickup,Yanli Pang,Agnieszka E. Gorska,Zhaoyang Li,Anna Chytil,Yipeng Geng,Jerome W. Gray,Harold L. Moses,Li Yang

DOI: https://doi.org/10.1158/0008-5472.22382760.v1

2023-01-01

Abstract:Supplementary Figures 1-7 from Gr-1+CD11b+ Myeloid Cells Tip the Balance of Immune Protection to Tumor Promotion in the Premetastatic Lung
Supplementary Figure S7 from Reconstitution of the Multiple Myeloma Microenvironment Following Lymphodepletion with BCMA CAR-T Therapy

Yazi Yang,Sen Qin,Mengyu Yang,Ting Wang,Ru Feng,Chunli Zhang,Enrun Zheng,Qinghua Li,Pengyu Xiang,Shangyong Ning,Xiaodong Xu,Xin Zuo,Shuai Zhang,Xiaoya Yun,Xuehong Zhou,Yue Wang,Lin He,Yongfeng Shang,Luyang Sun,Hui Liu

DOI: https://doi.org/10.1158/1078-0432.27013654

2024-01-01

Abstract:Supplementary Figure S7. BCMA CAR-T Therapy Attenuates BAFF/GALECTIN/MK Pathway-mediated Immunosuppression and Activates MIF Pathway-mediated Anti-MM Immunity.
Supplementary Figure 2 from LSECtin Expressed on Melanoma Cells Promotes Tumor Progression by Inhibiting Antitumor T-cell Responses

Feng Xu,Jing Liu,Di Liu,Biao Liu,Min Wang,Zhiyuan Hu,Xuemei Du,Li Tang,Fuchu He

DOI: https://doi.org/10.1158/0008-5472.22399947.v1

2023-01-01

Abstract:PDF file - 31KB, Supplementary Figure 2 Determination of concentration of IL-6 and IL-10 within tumor.
Supplementary Figure 9 from TGF-β Signaling in Myeloid Cells is Required for Tumor Metastasis

Yanli Pang,Sudheer Kumar Gara,Bhagelu R. Achyut,Zhaoyang Li,Hannah H. Yan,Chi‐Ping Day,Jonathan M. Weiss,Giorgio Trinchieri,John C. Morris,Li Yang

DOI: https://doi.org/10.1158/2159-8290.22530042.v1

2023-01-01

Abstract:Supplementary Figure 9 - PDF file 150K, Gating strategy, sorting efficiency, and TbetaRII expression in myeloid cell subsets
Supplementary Figure 5 from TLR2 Limits Development of Hepatocellular Carcinoma by Reducing IL18-Mediated Immunosuppression

Shinan Li,Rui Sun,Yongyan Chen,Wei H,Zhigang Tian

DOI: https://doi.org/10.1158/0008-5472.22407831.v1

2023-01-01

Abstract:S. Fig. 5. IL-18 silencing inhibits MDSC accumulation and restores T cell function.

Supplementary Fig. 1A from LILRB3 Supports Immunosuppressive Activity of Myeloid Cells and Tumor Development

Supplementary Figures S1-S8 from &lt;i&gt;a. Muciniphila&lt;/i&gt; Suppresses Colorectal Tumorigenesis by Inducing TLR2/NLRP3-Mediated M1-Like TAMs

Supplemetal Data from Genetic Ablation of Rbm38 Promotes Lymphomagenesis in the Context of Mutant P53 by Downregulating PTEN

Supplementary Figure from HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis

Supplementary Figure S3 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC

LILRB3 supports acute myeloid leukemia development and regulates T-cell antitumor immune responses through the TRAF2–cFLIP–NF-κB signaling axis

Supplementary Figure S6 from CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ

Supplementary Figure Legend from CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ

Supplementary Figure S5 from AMBRA1 Promotes TGFβ Signaling Via Nonproteolytic Polyubiquitylation of Smad4

Supplementary Figure S1 from CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ

Supplementary Figure 3 from TGF-β Signaling in Myeloid Cells is Required for Tumor Metastasis

Supplementary Figure 7 from TGF-β Signaling in Myeloid Cells is Required for Tumor Metastasis

Figure S4 from Disrupting LILRB4/APOE Interaction by an Efficacious Humanized Antibody Reverses T-cell Suppression and Blocks AML Development

Supplementary Figure 8 from TGF-β Signaling in Myeloid Cells is Required for Tumor Metastasis

Supplementary Figure S4 from CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ

Supplemental Figures S1-S11 from PBX3 and MEIS1 Cooperate in Hematopoietic Cells to Drive Acute Myeloid Leukemias Characterized by a Core Transcriptome of the MLL-Rearranged Disease

Supplementary Figures 1-7 from Gr-1+CD11b+ Myeloid Cells Tip the Balance of Immune Protection to Tumor Promotion in the Premetastatic Lung

Supplementary Figure S7 from Reconstitution of the Multiple Myeloma Microenvironment Following Lymphodepletion with BCMA CAR-T Therapy

Supplementary Figure 2 from LSECtin Expressed on Melanoma Cells Promotes Tumor Progression by Inhibiting Antitumor T-cell Responses

Supplementary Figure 9 from TGF-β Signaling in Myeloid Cells is Required for Tumor Metastasis

Supplementary Figure 5 from TLR2 Limits Development of Hepatocellular Carcinoma by Reducing IL18-Mediated Immunosuppression

Supplementary Figures S1-S8 from <i>a. Muciniphila</i> Suppresses Colorectal Tumorigenesis by Inducing TLR2/NLRP3-Mediated M1-Like TAMs